ZIKV NS2B-NS3 protease dose response screening assay v1
Purpose: performing dose-response test of selected compounds from screening experiments against ZIKV NS2B-NS3 to confirm efficacy General description: This protocol details the fluorescent assays for ZIKV NS2B-NS3 cleavage of substrate Bz-Nle-KRR-AMC peptide. This method measures the fluorescence from the released AMC product as a result of the enzymatic reaction. When hydrolyzed, AMC is liberated from the peptide substrate. Excitation of AMC at 350 nm emits a resonant energy of 450 nm. When the enzyme is inhibited, the fluorescence signal will decrease as a result of lower enzyme activity. The screening method is validated by calculating the Z prime number of each plate, and the percentage of inhibition is calculated and then evaluated for inhibitory efficacy. Outcome: hits were selected from screening assays with more than 50% inhibition and some hits demonstrated dose-response
Authors
- Jiyun Zhu (ORCID: https://orcid.org/0000-0002-8861-5450)
- Haim Michael Barr (ORCID: https://orcid.org/0000-0001-9192-3983)
- Noa Lahav
Institutions
- Weizmann Institute of Science (IL)
Publication Details
- Published
- 2024-11-03
- DOI
- https://doi.org/10.17504/protocols.io.x54v9r83zv3e/v1
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases